These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15004411)

  • 21. A comparison of the hypotensive and hypoglycaemic actions of an angiotensin converting enzyme inhibitor, an AT1a antagonist and troglitazone.
    Chen S; Noguchi Y; Izumida T; Tatebe J; Katayama S
    J Hypertens; 1996 Nov; 14(11):1325-30. PubMed ID: 8934361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of imidapril on endothelin-1 and ACE gene expression in failing hearts of salt-sensitive hypertensive rats.
    Kobayashi N; Hara K; Higashi T; Matsuoka H
    Am J Hypertens; 2000 Oct; 13(10):1088-96. PubMed ID: 11041163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increases myocardial glucose uptake in Zucker fatty rats: Studies comparing a vasopeptidase inhibitor, angiotensin-converting enzyme inhibitor, and angiotensin II type I receptor blocker.
    Wang CH; Leung N; Lapointe N; Szeto L; Uffelman KD; Giacca A; Rouleau JL; Lewis GF
    Circulation; 2003 Apr; 107(14):1923-9. PubMed ID: 12668518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of angiotensin converting enzyme and angiotensin II receptors in the atherosclerotic aorta of high-cholesterol fed Cynomolgus monkeys.
    Song K; Shiota N; Takai S; Takashima H; Iwasaki H; Kim S; Miyazaki M
    Atherosclerosis; 1998 May; 138(1):171-82. PubMed ID: 9678783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic and pharmacodynamic study of imidaprilat, an active metabolite of imidapril, a new angiotensin-converting enzyme inhibitor, in spontaneously hypertensive rats.
    Yamanaka K; Takehara N; Murata K; Banno K; Sato T
    J Pharm Biomed Anal; 1997 Aug; 15(12):1851-9. PubMed ID: 9278890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity.
    Furuhashi M; Ura N; Takizawa H; Yoshida D; Moniwa N; Murakami H; Higashiura K; Shimamoto K
    J Hypertens; 2004 Oct; 22(10):1977-82. PubMed ID: 15361770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steady-state pharmacokinetics and pharmacodynamics of imidaprilat, an active metabolite of imidapril, a new angiotensin-converting enzyme inhibitor in spontaneously hypertensive rats.
    Yamanaka K; Takehara N; Murata K; Banno K; Sato T
    J Pharm Sci; 1996 Nov; 85(11):1234-7. PubMed ID: 8923331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of bradykinin, nitric oxide, and angiotensin II type 2 receptor in imidapril-induced angiogenesis.
    Li P; Kondo T; Numaguchi Y; Kobayashi K; Aoki M; Inoue N; Okumura K; Murohara T
    Hypertension; 2008 Feb; 51(2):252-8. PubMed ID: 18086946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertension.
    Fogari R; Zoppi A; Salvadeo SA; Mugellini A; Lazzari P; Santoro T; Derosa G
    Hypertens Res; 2011 Apr; 34(4):509-15. PubMed ID: 21179101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat.
    Lee MK; Miles PD; Khoursheed M; Gao KM; Moossa AR; Olefsky JM
    Diabetes; 1994 Dec; 43(12):1435-9. PubMed ID: 7958495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Studies on angiotensin I converting enzyme (ACE): inhibitory effect of imidapril, a novel ACE inhibitor (II). Inhibition of various tissue ACEs ex vivo].
    Hashimoto Y; Kubo M; Sugaya T; Minobe S; Watanabe T; Yamamura M; Matsuoka Y
    Nihon Yakurigaku Zasshi; 1994 Jul; 104(1):51-61. PubMed ID: 8076891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quinapril treatment restores the vasodilator action of insulin in fructose-hypertensive rats.
    Uchida T; Okumura K; Ito T; Kamiya H; Nishimoto Y; Yamada M; Tomida T; Matsui H; Hayakawa T
    Clin Exp Pharmacol Physiol; 2002; 29(5-6):381-5. PubMed ID: 12010179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible interactions between angiotensin II and insulin: effects on glucose and lipid metabolism in vivo and in vitro.
    Patiag D; Qu X; Gray S; Idris I; Wilkes M; Seale JP; Donnelly R
    J Endocrinol; 2000 Dec; 167(3):525-31. PubMed ID: 11115780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic insulin infusion normalizes blood pressure and the gene expressions of angiotensin II type 1 receptor in fructose-fed rats.
    Fukui T; Hirano T; Shiraishi Y; Nagashima M; Adachi M
    Hypertens Res; 2008 Jan; 31(1):127-33. PubMed ID: 18360027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional interaction of AT1 and AT2 receptors in fructose-induced insulin resistance and hypertension in rats.
    Hsieh PS; Tai YH; Loh CH; Shih KC; Cheng WT; Chu CH
    Metabolism; 2005 Feb; 54(2):157-64. PubMed ID: 15690308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement of insulin resistance by miracle fruit (Synsepalum dulcificum) in fructose-rich chow-fed rats.
    Chen CC; Liu IM; Cheng JT
    Phytother Res; 2006 Nov; 20(11):987-92. PubMed ID: 16941611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular Angiotensin type 1 receptor expression is associated with vascular dysfunction, oxidative stress and inflammation in fructose-fed rats.
    Nyby MD; Abedi K; Smutko V; Eslami P; Tuck ML
    Hypertens Res; 2007 May; 30(5):451-7. PubMed ID: 17587757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A high-fructose diet impairs Akt and PKCzeta phosphorylation and GLUT4 translocation in rat skeletal muscle.
    Li P; Koike T; Qin B; Kubota M; Kawata Y; Jia YJ; Oshida Y
    Horm Metab Res; 2008 Aug; 40(8):528-32. PubMed ID: 18500676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cough-challenge trial with a new angiotensin-converting enzyme inhibitor, imidapril.
    Shionoiri H; Takasaki I; Minamisawa K; Ueda S; Kihara M; Shindo K; Hiroto S; Sugimoto K; Himeno H; Naruse M; Nagamochi I; Yasuda G
    J Clin Pharmacol; 1998 May; 38(5):442-6. PubMed ID: 9602958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Olmesartan medoxomil, an angiotensin II receptor blocker ameliorates insulin resistance and decreases triglyceride production in fructose-fed rats.
    Okada K; Hirano T; Ran J; Adachi M
    Hypertens Res; 2004 Apr; 27(4):293-9. PubMed ID: 15127887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.